Feb 10, 2021
– The CE Mark for the Alveo be.well COVID-19 Flex Test is Alveo’s first regulatory approval- Alveo plans to submit the test for approval by the U.S. Food and Drug Administration under emergency use authorization Alameda, CA – 02/10/21 – Alveo Technologies, Inc....
Nov 2, 2020
Infectious Disease Diagnostic Innovator Receives Grant from the Bill & Melinda Gates Foundation to Advance Accessibility and Commercialization for At-Home COVID-19 Testing Alameda, CA – 11/2/20 – Alveo Technologies, today announced it has been awarded a grant to...
Sep 14, 2020
Cutting-Edge Infectious Disease Diagnostics Company Brings on Former Aetna EVP to Drive Business Strategy and Support Widespread Adoption of Diagnostic Platform Alameda, CA – September 15, 2020 – Alveo Technologies, a leader in developing novel technologies that...
Aug 17, 2020
Seasoned Healthcare Financial Expert to Drive Strategic Growth for Diagnostic Tech Startup Alameda, CA – August 18, 2020 – Alveo Technologies, a leader in developing noveltechnologies that enable real-time, low-cost, at-home molecular detection of infectious disease,...
Jul 6, 2020
Researcher Lends Clinical Expertise to Evaluate New Diagnostic Technologies and Support Science Research Alameda, CA – July 7, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of...
May 11, 2020
Biopharma Leader to Provide Expertise to Develop and Deliver World’s First At-Home Rapid Test for Respiratory Viral Infections Alameda, CA – May 12, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost...
Apr 30, 2020
Alameda, CA – April 30, 2020 – Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, announced today that it has entered into a research collaboration with Janssen...
Feb 20, 2020
We are thrilled to announce today that in February 2020 Alveo Technologies was presented with a Food and Drug Branch License (FDB License) after an in-person inspection by a Food and Drug Investigator from the State of California Food and Drug Branch of the Food and...
Feb 1, 2020
Our company is delighted to announce today, February 1, 2020, that Pooja Goel, Managing Director and Healthcare Practice Lead at Virgo Investment Group, LLC, is joining Alveo’s Scientific Advisory Board. Having held key operational roles responsible for new market and...
May 1, 2019
We are pleased to announce that famed American Geneticist George Church will be joining Alveo’s Scientific Advisory Board. With extensive background in medical diagnostics, including founding application-based companies, George will bring valuable expertise to our...
error: Content Restricted
